Atorvastatin

esperion

More Positive Test Results For Plymouth Firm’s Cholesterol Drug

Esperion Therapeutics Inc. Tuesday announced positive results from a Phase 2a study of its drug candidate ETC-1002 when added to statin therapy in patients with high levels of low density lipoprotein cholesterol, the so-called bad cholesterol, in their blood.

WWJ Newsradio 950–09/03/2013

Follow

Get every new post delivered to your Inbox.

Join 2,307 other followers